Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (4982)	8/17/1998 6:30:00 PM
From: BigKNY3	Read Replies (2) \| Respond to of 9523

Vlad <<I think that once the new #s stop declining and the refills stop increasing we will have reached an equilibrium. Do you think an advertising blitz will make a difference in Viagra sales? I doubt it since the media has already done all the advertising Pfizer could want. Anybody who doesn't know about Viagra must live on another planet.>> Vlad: Thanks for the Rx numbers. The Viagra refill growth is a strong indicator of patient satisfaction and I anticipate continued growth. It is very difficult to predict short-term Viagra new Rxs in view of the initial pent-up demand and the circulation-seeking media blitz. However, I believe there is a much higher upside potential as PFE educates primary care physicians and their potential patients on the proper use of Viagra. Good luck! BigKNY3